Developer docs
API playgroundTry for free, no card

Search company profiles

Imperial College Healthcare NHS Trust

Full company profile

uuid000549a

Namestring
Imperial College Healthcare NHS Trust
Legal namestring
Imperial College Healthcare NHS Trust
Websiteurl
imperial.nhs.uk
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Imperial College Healthcare NHS Trust is a statutory NHS Trust and one of England's largest academic health science centres, operating five hospitals in London — St Mary's (Paddington), Hammersmith, Queen Charlotte's & Chelsea, Charing Cross, and the Western Eye — alongside three community diagnostic centres in Willesden, Wembley, and North Paddington. It serves a catchment of approximately 2.4 million residents across eight north-west London boroughs and employs more than 10,000 staff, providing emergency, acute, maternity, and tertiary specialist services including the world's largest National Gestational Trophoblastic Centre at Charing Cross Hospital.

The Trust is structurally tied to Imperial College London, functioning as the clinical arm of an academic medical centre that integrates patient care with translational research and teaching through the NIHR Imperial Biomedical Research Centre and the Imperial Health Knowledge Bank. Core technology infrastructure comprises a Microsoft Azure and Snowflake cloud-based data environment supporting research across millions of patient records, supplemented by AI clinical tools (Oracle Health Clinical AI Agent for ambient clinical documentation, Google mammography AI as second reader, Dosium's Touchdose for prescribing safety, and Cepheid rapid molecular diagnostics). Specialist clinical offerings include focal therapy for prostate cancer, hypoglossal nerve stimulation for sleep apnoea, high-intensity focused ultrasound for twin-twin transfusion syndrome, and advanced cancer, cardiovascular, and neurological services.

Revenue is principally derived from NHS England block commissioning and North West London Integrated Care Board contracts, supplemented by competitive research grants (e.g., £3.1 million Gates/Novo Nordisk/Wellcome Fleming Initiative funding), Imperial Private Healthcare, and charitable support from Imperial Health Charity. The Trust is part of the North West London Acute Provider Collaborative (board-in-common arrangement) and is currently executing a £2.2 billion redevelopment of St Mary's Hospital under the government's New Hospital Programme. Its overall CQC rating is 'Requires Improvement' (2015), with maternity services at Queen Charlotte's & Chelsea and St Mary's achieving London's first 'Outstanding' rating in that category in 2019.

Short descriptiontext

Imperial College Healthcare NHS Trust is a London-based NHS Trust and academic health science centre operating five hospitals and three community diagnostic centres, serving 2.4 million north-west London residents through emergency, acute, maternity, and specialist tertiary services in partnership with Imperial College London.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
NHS hospital services, acute healthcare, specialist clinical services, clinical research, academic healthcare
Industry2 codes
1Safety-Net & Public Hospitals
CodeHLAFAAADPrimaryYes
2Student Health & University Primary Care Clinics
CodeHLAFAGAKPrimaryNo
NAICS code2 codes
  • General Medical and Surgical Hospitals6221
  • General Medical and Surgical Hospitals622110
SIC code2 codes
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Hospitals8060
Product category
Acute Hospital and Specialist Healthcare Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1NHS England Core Funding
TypeSubscription Recurring
Description

NHS Trusts receive core funding from NHS England based on weighted capitation formulas that account for population size, demographics, and health needs. This forms the primary revenue stream for operational costs.

imperial.nhs.uk
2Clinical Commissioning Group Contracts
TypeSubscription Recurring
Description

Revenue from clinical commissioning groups (CCGs) and integrated care boards for commissioned healthcare services based on service level agreements.

imperial.nhs.uk
3Research Grants and Funding
TypeManaged Services
Description

Competitive grant funding from bodies including NIHR, The Gates Foundation, Wellcome, and Novo Nordisk Foundation for specific research programmes and clinical trials.

imperial.nhs.uk
4Private Healthcare Services
TypeProfessional Services
Description

Imperial Private Healthcare provides private patient services for those choosing private care, generating additional revenue streams.

imperial.nhs.uk
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Imperial College Healthcare NHS Trust delivers comprehensive NHS healthcare services — including emergency, acute, maternity, neonatal, and specialist care — across five London hospitals and three community diagnostic centres serving a population of 2.4 million in north west London. The Trust operates as an Academic Health Science Centre in partnership with Imperial College London, integrating clinical service delivery with translational research, clinical trials, and medical education. It also provides private patient services through Imperial Private Healthcare and runs world-renowned specialist centres including the National Gestational Trophoblastic Centre, focal therapy for prostate cancer, and hypoglossal nerve stimulation for sleep apnoea.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Focal therapy for prostate cancer achieved five-fold lower risk of side effects compared to conventional treatments, with only 2 deaths from prostate cancer in nearly 3,500 men tracked over a decade
+3 more records
Product overview1 text field

Imperial College Healthcare NHS Trust operates five London hospitals (St Mary's, Hammersmith, Charing Cross, Queen Charlotte's & Chelsea, Western Eye) providing emergency, acute, maternity, and specialist care. The Trust functions as an academic medical centre in partnership with Imperial College London, integrating clinical care with research and education. Key specialist services include the National Gestational Trophoblastic Centre (world's largest), focal therapy for prostate cancer, hypoglossal nerve stimulation for sleep apnoea, and HIFU for twin-twin transfusion syndrome. The Trust is implementing AI technologies including Oracle Health Clinical AI Agent for automated clinical documentation, Google mammography AI for breast cancer screening, and Touchdose for prescribing error reduction. Research infrastructure includes the Imperial Health Knowledge Bank for patient recruitment and the Fleming Initiative for antimicrobial resistance research.

Product and service7 records
1National Gestational Trophoblastic Centre
CategorySpecialist clinical service
2Hypoglossal Nerve Stimulation (HGNS) for Sleep Apnoea
CategorySpecialist clinical service
3Focal Therapy for Prostate Cancer
CategorySpecialist clinical service
4North West London Elective Orthopaedic Centre
CategorySpecialist clinical service
5Imperial Health Knowledge Bank
CategoryResearch service
6Clinical Research Services
CategoryResearch service
7Imperial Private Healthcare
CategoryPrivate healthcare services
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

24-month partnership programme to improve population health and advance health equity across north west London. The charity is investing in 10 to 20 joint population health projects with initial focus on maternity services, children's health, cancer care, and outpatient services.

Strategic tierMajorTypeTechnology or Integration
Description

Landmark 30-month TRACE-CPE study evaluating rapid molecular screening for carbapenemase-producing Enterobacterales (CPE) compared to standard 48-hour culture testing. Study assesses clinical outcomes, transmission patterns, patient experience, and cost implications.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partner NHS Trust in the TRACE-CPE study evaluating rapid CPE screening across two major London NHS Trusts.

Strategic tierMajorTypeTechnology or Integration
Description

Clinical AI Agent pilot programme using ambient voice technology for auto-drafting patient notes. Imperial College Healthcare is now broadly deploying the solution following successful pilots that reduced documentation time by approximately 40%.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NHS Trust that piloted Oracle Health Clinical AI Agent alongside Imperial College Healthcare NHS Trust and Milton Keynes University Hospital.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

NHS Trust that piloted Oracle Health Clinical AI Agent alongside Imperial College Healthcare NHS Trust and Barts Health NHS Trust.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner providing research leadership, teaching capabilities, and innovation infrastructure. Partnership enables rapid translation of research from bench to bedside and supports world-class medical education.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Board in common arrangement with three other acute NHS trusts meeting four times annually in public. Collaborative includes Chelsea and Westminster Hospital NHS FT, London North West University Healthcare NHS Trust, and The Hillingdon Hospitals NHS FT.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

Appointed to lead masterplanning and planning application for the £2.2 billion redevelopment of St Mary's Hospital in Paddington.

Strategic tierMajorTypeImplementation/ SI/ Consulting Partner
Description

Appointed to lead masterplanning and planning application for the £2.2 billion redevelopment of St Mary's Hospital in Paddington.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Local authority partnership through Pathway Bond initiative connecting students with work placements at NHS trusts and biotech firms, backed by partnership with Imperial College London.

12Paddington Life Sciences Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration of life science and community organisations with the Trust and Imperial College London, centred around St Mary's Hospital. Driving improvements in digital inclusion and providing opportunities for local residents.

imperial.nhs.uk
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration leveraging interplay between sport, health and wellbeing, developing community-based programmes combining exercise, physical activity and peer support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led by Imperial College London's Fleming Initiative, building global antimicrobial resistance intelligence platform and conducting antibiotic discovery research with £3.1 million funding.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major London academic NHS Foundation Trust operating multiple acute hospitals with UCL Medical School affiliation, providing tertiary services across north and central London. Comparable scale and academic partnership model to Imperial, with overlapping specialist services.

TypeDirect peer
Description

West London acute NHS Foundation Trust with two hospital sites, partner in the North West London Acute Provider Collaborative board-in-common arrangement with Imperial. Closely comparable peer in terms of geography, size, and shared governance structure.

TypeDirect peer
Description

Largest NHS Trust in England, operating multiple acute hospitals in East London with academic partnership with Queen Mary University of London. Direct comparable on scale, academic-medical-centre model, and AI deployment; jointly piloted the Oracle Health Clinical AI Agent with Imperial.

TypeDirect peer
Description

Large London academic NHS Foundation Trust co-located with King's College London, offering comparable specialist tertiary services across two acute hospital sites. Directly comparable to Imperial as a research-led London teaching trust; explicitly named as Imperial's partner in the TRACE-CPE study.

TypeDirect peer
Description

University hospital NHS Trust that co-piloted the Oracle Health Clinical AI Agent ambient documentation tool with Imperial. Comparable as an early adopter of clinical AI for productivity gains and as a university-affiliated acute provider.

TypeDirect peer
Description

Major London academic NHS Foundation Trust with strong research and teaching links to King's College London, providing comprehensive tertiary services across multiple sites. Highly comparable as an academic tertiary provider competing for specialist referrals in the London catchment.

TypeDirect peer
Description

Central London academic NHS Foundation Trust operating specialist and acute services alongside UCL, with focus on research-driven specialty care. Directly comparable academic medical centre structure with similar translational research infrastructure and London specialist referral base.

TypeDirect peer
Description

South London academic NHS Foundation Trust with teaching links to St George's, University of London, providing comprehensive acute and specialist services. Comparable as a London teaching hospital trust competing for specialist referrals and research talent.

TypeBroad incumbent
Description

Privately operated US-backed hospital in central London competing for complex tertiary and private patient revenue. Relevant comparator on specialty care quality, technology adoption, and London catchment, although operating under a private rather than NHS funding model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Imperial College Healthcare NHS Trust

Acute Hospital and Specialist Healthcare Servicesimperial.nhs.uk

Imperial College Healthcare NHS Trust is a London-based NHS Trust and academic health science centre operating five hospitals and three community diagnostic centres, serving 2.4 million north-west London residents through emergency, acute, maternity, and specialist tertiary services in partnership with Imperial College London.

What Imperial College Healthcare NHS Trust does

Imperial College Healthcare NHS Trust is a statutory NHS Trust and one of England's largest academic health science centres, operating five hospitals in London — St Mary's (Paddington), Hammersmith, Queen Charlotte's & Chelsea, Charing Cross, and the Western Eye — alongside three community diagnostic centres in Willesden, Wembley, and North Paddington. It serves a catchment of approximately 2.4 million residents across eight north-west London boroughs and employs more than 10,000 staff, providing emergency, acute, maternity, and tertiary specialist services including the world's largest National Gestational Trophoblastic Centre at Charing Cross Hospital.

The Trust is structurally tied to Imperial College London, functioning as the clinical arm of an academic medical centre that integrates patient care with translational research and teaching through the NIHR Imperial Biomedical Research Centre and the Imperial Health Knowledge Bank. Core technology infrastructure comprises a Microsoft Azure and Snowflake cloud-based data environment supporting research across millions of patient records, supplemented by AI clinical tools (Oracle Health Clinical AI Agent for ambient clinical documentation, Google mammography AI as second reader, Dosium's Touchdose for prescribing safety, and Cepheid rapid molecular diagnostics). Specialist clinical offerings include focal therapy for prostate cancer, hypoglossal nerve stimulation for sleep apnoea, high-intensity focused ultrasound for twin-twin transfusion syndrome, and advanced cancer, cardiovascular, and neurological services.

Revenue is principally derived from NHS England block commissioning and North West London Integrated Care Board contracts, supplemented by competitive research grants (e.g., £3.1 million Gates/Novo Nordisk/Wellcome Fleming Initiative funding), Imperial Private Healthcare, and charitable support from Imperial Health Charity. The Trust is part of the North West London Acute Provider Collaborative (board-in-common arrangement) and is currently executing a £2.2 billion redevelopment of St Mary's Hospital under the government's New Hospital Programme. Its overall CQC rating is 'Requires Improvement' (2015), with maternity services at Queen Charlotte's & Chelsea and St Mary's achieving London's first 'Outstanding' rating in that category in 2019.

Imperial College Healthcare NHS Trust firmographics

Firmographics
Name
Imperial College Healthcare NHS Trust
Legal name
Imperial College Healthcare NHS Trust
Website
https://imperial.nhs.uk
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Imperial College Healthcare NHS Trust is a London-based NHS Trust and academic health science centre operating five hospitals and three community diagnostic centres, serving 2.4 million north-west London residents through emergency, acute, maternity, and specialist tertiary services in partnership with Imperial College London.
Ownership category
akta.pro rank

Imperial College Healthcare NHS Trust industry classification

Industry
Product category
Acute Hospital and Specialist Healthcare Services
NAICS
General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)
akta.pro primary industry
Safety-Net & Public Hospitals (HLAFAAAD)
akta.pro secondary industry
Student Health & University Primary Care Clinics (HLAFAGAK)

Keywords

  • NHS hospital services
  • Acute healthcare
  • Specialist clinical services
  • Clinical research
  • Academic healthcare

Where Imperial College Healthcare NHS Trust is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices8 records

Markets served

Imperial College Healthcare NHS Trust business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

  1. NHS England Core Funding: NHS Trusts receive core funding from NHS England based on weighted capitation formulas that account for population size, demographics, and health needs. This forms the primary revenue stream for operational costs.
  2. Clinical Commissioning Group Contracts: Revenue from clinical commissioning groups (CCGs) and integrated care boards for commissioned healthcare services based on service level agreements.
  3. Research Grants and Funding: Competitive grant funding from bodies including NIHR, The Gates Foundation, Wellcome, and Novo Nordisk Foundation for specific research programmes and clinical trials.
  4. Private Healthcare Services: Imperial Private Healthcare provides private patient services for those choosing private care, generating additional revenue streams.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Imperial College Healthcare NHS Trust product offering

Product offering

Core offering

Imperial College Healthcare NHS Trust delivers comprehensive NHS healthcare services — including emergency, acute, maternity, neonatal, and specialist care — across five London hospitals and three community diagnostic centres serving a population of 2.4 million in north west London. The Trust operates as an Academic Health Science Centre in partnership with Imperial College London, integrating clinical service delivery with translational research, clinical trials, and medical education. It also provides private patient services through Imperial Private Healthcare and runs world-renowned specialist centres including the National Gestational Trophoblastic Centre, focal therapy for prostate cancer, and hypoglossal nerve stimulation for sleep apnoea.

Product overview

Imperial College Healthcare NHS Trust operates five London hospitals (St Mary's, Hammersmith, Charing Cross, Queen Charlotte's & Chelsea, Western Eye) providing emergency, acute, maternity, and specialist care. The Trust functions as an academic medical centre in partnership with Imperial College London, integrating clinical care with research and education. Key specialist services include the National Gestational Trophoblastic Centre (world's largest), focal therapy for prostate cancer, hypoglossal nerve stimulation for sleep apnoea, and HIFU for twin-twin transfusion syndrome. The Trust is implementing AI technologies including Oracle Health Clinical AI Agent for automated clinical documentation, Google mammography AI for breast cancer screening, and Touchdose for prescribing error reduction. Research infrastructure includes the Imperial Health Knowledge Bank for patient recruitment and the Fleming Initiative for antimicrobial resistance research.

Differentiator

Problem solved

Functional benefit

Products and services

  • National Gestational Trophoblastic Centre
  • Hypoglossal Nerve Stimulation (HGNS) for Sleep Apnoea
  • Focal Therapy for Prostate Cancer
  • North West London Elective Orthopaedic Centre
  • Imperial Health Knowledge Bank
  • Clinical Research Services
  • Imperial Private Healthcare

Quantifiable outcome

  • Focal therapy for prostate cancer achieved five-fold lower risk of side effects compared to conventional treatments, with only 2 deaths from prostate cancer in nearly 3,500 men tracked over a decade
  • +3 more outcomes

Companies that use Imperial College Healthcare NHS Trust

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Imperial College Healthcare NHS Trust technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature5 records

Imperial College Healthcare NHS Trust partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, major and minor.

  • Imperial Health CharitycoreStrategic or Co-development Partner24-month partnership programme to improve population health and advance health equity across north west London. The charity is investing in 10 to 20 joint population health projects with initial focus on maternity services, children's health, cancer care, and outpatient services.
  • CepheidmajorTechnology or IntegrationLandmark 30-month TRACE-CPE study evaluating rapid molecular screening for carbapenemase-producing Enterobacterales (CPE) compared to standard 48-hour culture testing. Study assesses clinical outcomes, transmission patterns, patient experience, and cost implications.
  • Guy's and St Thomas' NHS Foundation TrustmajorStrategic or Co-development PartnerPartner NHS Trust in the TRACE-CPE study evaluating rapid CPE screening across two major London NHS Trusts.
  • Oracle HealthmajorTechnology or IntegrationClinical AI Agent pilot programme using ambient voice technology for auto-drafting patient notes. Imperial College Healthcare is now broadly deploying the solution following successful pilots that reduced documentation time by approximately 40%.
  • Barts Health NHS TrustminorStrategic or Co-development PartnerNHS Trust that piloted Oracle Health Clinical AI Agent alongside Imperial College Healthcare NHS Trust and Milton Keynes University Hospital.
  • Milton Keynes University HospitalminorStrategic or Co-development PartnerNHS Trust that piloted Oracle Health Clinical AI Agent alongside Imperial College Healthcare NHS Trust and Barts Health NHS Trust.
  • Imperial College LondoncoreStrategic or Co-development PartnerAcademic partner providing research leadership, teaching capabilities, and innovation infrastructure. Partnership enables rapid translation of research from bench to bedside and supports world-class medical education.
  • North West London Acute Provider CollaborativecoreStrategic or Co-development PartnerBoard in common arrangement with three other acute NHS trusts meeting four times annually in public. Collaborative includes Chelsea and Westminster Hospital NHS FT, London North West University Healthcare NHS Trust, and The Hillingdon Hospitals NHS FT.
  • Stanhope PlcmajorImplementation/ SI/ Consulting PartnerAppointed to lead masterplanning and planning application for the £2.2 billion redevelopment of St Mary's Hospital in Paddington.
  • Allies and MorrisonmajorImplementation/ SI/ Consulting PartnerAppointed to lead masterplanning and planning application for the £2.2 billion redevelopment of St Mary's Hospital in Paddington.
  • Hammersmith & Fulham CouncilmajorStrategic or Co-development PartnerLocal authority partnership through Pathway Bond initiative connecting students with work placements at NHS trusts and biotech firms, backed by partnership with Imperial College London.
  • Paddington Life Sciences PartnerscoreStrategic or Co-development PartnerCollaboration of life science and community organisations with the Trust and Imperial College London, centred around St Mary's Hospital. Driving improvements in digital inclusion and providing opportunities for local residents.
  • Chelsea FC FoundationminorStrategic or Co-development PartnerCollaboration leveraging interplay between sport, health and wellbeing, developing community-based programmes combining exercise, physical activity and peer support.
  • Fleming InitiativecoreStrategic or Co-development PartnerLed by Imperial College London's Fleming Initiative, building global antimicrobial resistance intelligence platform and conducting antibiotic discovery research with £3.1 million funding.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Imperial College Healthcare NHS Trust competitors and assessment

Company assessment

Others

Direct peers

  • Royal Free London NHS Foundation Trust: Major London academic NHS Foundation Trust operating multiple acute hospitals with UCL Medical School affiliation, providing tertiary services across north and central London. Comparable scale and academic partnership model to Imperial, with overlapping specialist services.
  • Chelsea and Westminster Hospital NHS Foundation Trust: West London acute NHS Foundation Trust with two hospital sites, partner in the North West London Acute Provider Collaborative board-in-common arrangement with Imperial. Closely comparable peer in terms of geography, size, and shared governance structure.
  • Barts Health NHS Trust: Largest NHS Trust in England, operating multiple acute hospitals in East London with academic partnership with Queen Mary University of London. Direct comparable on scale, academic-medical-centre model, and AI deployment; jointly piloted the Oracle Health Clinical AI Agent with Imperial.
  • Guy's and St Thomas' NHS Foundation Trust: Large London academic NHS Foundation Trust co-located with King's College London, offering comparable specialist tertiary services across two acute hospital sites. Directly comparable to Imperial as a research-led London teaching trust; explicitly named as Imperial's partner in the TRACE-CPE study.
  • Milton Keynes University Hospital NHS Foundation Trust: University hospital NHS Trust that co-piloted the Oracle Health Clinical AI Agent ambient documentation tool with Imperial. Comparable as an early adopter of clinical AI for productivity gains and as a university-affiliated acute provider.
  • King's College Hospital NHS Foundation Trust: Major London academic NHS Foundation Trust with strong research and teaching links to King's College London, providing comprehensive tertiary services across multiple sites. Highly comparable as an academic tertiary provider competing for specialist referrals in the London catchment.
  • University College London Hospitals NHS Foundation Trust: Central London academic NHS Foundation Trust operating specialist and acute services alongside UCL, with focus on research-driven specialty care. Directly comparable academic medical centre structure with similar translational research infrastructure and London specialist referral base.
  • St George's University Hospitals NHS Foundation Trust: South London academic NHS Foundation Trust with teaching links to St George's, University of London, providing comprehensive acute and specialist services. Comparable as a London teaching hospital trust competing for specialist referrals and research talent.

Broad incumbents

  • Cleveland Clinic London: Privately operated US-backed hospital in central London competing for complex tertiary and private patient revenue. Relevant comparator on specialty care quality, technology adoption, and London catchment, although operating under a private rather than NHS funding model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Imperial College Healthcare NHS Trust social profiles

Digital presence

Imperial College Healthcare NHS Trust compliance and trust

Trust signal

Compliance1 record

Imperial College Healthcare NHS Trust financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Imperial College Healthcare NHS Trust leadership team

Management profile

Number of profiles

Profiles12 records

Imperial College Healthcare NHS Trust funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Imperial College Healthcare NHS Trust M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imperial College Healthcare NHS Trust

What does Imperial College Healthcare NHS Trust do?

Imperial College Healthcare NHS Trust delivers comprehensive NHS healthcare services — including emergency, acute, maternity, neonatal, and specialist care — across five London hospitals and three community diagnostic centres serving a population of 2.4 million in north west London. The Trust operates as an Academic Health Science Centre in partnership with Imperial College London, integrating clinical service delivery with translational research, clinical trials, and medical education. It also provides private patient services through Imperial Private Healthcare and runs world-renowned specialist centres including the National Gestational Trophoblastic Centre, focal therapy for prostate cancer, and hypoglossal nerve stimulation for sleep apnoea.

Is Imperial College Healthcare NHS Trust a public or private company?

Imperial College Healthcare NHS Trust is a private company. It is classified as state government owned and is currently operating.

When was Imperial College Healthcare NHS Trust founded?

Imperial College Healthcare NHS Trust was founded in 2004. It employs 5,001 to 10,000 people.

Where is Imperial College Healthcare NHS Trust based?

Imperial College Healthcare NHS Trust is headquartered in London, United Kingdom, in the Europe region.

How does Imperial College Healthcare NHS Trust make money?

Four revenue lines are on record. NHS England Core Funding is the primary driver. The others are clinical Commissioning Group Contracts, research Grants and Funding and private Healthcare Services.

Who are Imperial College Healthcare NHS Trust's main competitors?

Manchester University NHS Foundation Trust is listed as an others. Direct peers are Royal Free London NHS Foundation Trust, Chelsea and Westminster Hospital NHS Foundation Trust, Barts Health NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Milton Keynes University Hospital NHS Foundation Trust, King's College Hospital NHS Foundation Trust, University College London Hospitals NHS Foundation Trust and St George's University Hospitals NHS Foundation Trust. Cleveland Clinic London is listed as a broad incumbent.

Does Imperial College Healthcare NHS Trust have an API?

No public API is recorded for Imperial College Healthcare NHS Trust.

What industry is Imperial College Healthcare NHS Trust in?

Imperial College Healthcare NHS Trust's product category is Acute Hospital and Specialist Healthcare Services. Its primary akta.pro industry code is HLAFAAAD, Safety-Net & Public Hospitals, with a secondary code of HLAFAGAK, Student Health & University Primary Care Clinics. Its NAICS code is 6221 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BBCSt Mary's rebuild plans unveiled for 'crumbling' London hospitalImperial College Healthcare NHS Trust released detailed plans for rebuilding St Mary's Hospital in Paddington, with a new 30-storey building on a smaller footprint. The trust cites a large maintenance backlog and seeks additional financing to accelerate work, with a planning application targeted for spring 2027.GlobeNewswirePhilips delivers solid comparable sales growth and margin in Q2; reiterates full year comparable sales growth outlook; Adjusted EBITA and free cash flow outlook increased to reflect US tariff refundRoyal Philips reported Q2 2026 group sales of EUR 4.4 billion with 4% comparable sales growth driven by all business segments, while adjusted EBITA margin increased to 16.4%, boosted by a US tariff refund benefit of EUR 186 million. The company reiterated its full-year comparable sales growth outlook of 3%-4.5% and raised its adjusted EBITA margin guidance to 13.5%-14.0% and free cash flow outlook to EUR 1.5-1.7 billion, both updated to reflect the tariff refund. Philips also announced new product launches including SmartIQ for its Azurion platform and AI-powered Titanion MR system, along with enterprise imaging partnerships with a US health system and Imperial College Healthcare NHS Trust in the UK.The IndependentProstate cancer treatment that helped Jeremy Clarkson and Lord David Cameron as effective as radiotherapyA study from Imperial College London and Imperial College Healthcare NHS Trust, published in European Urology, found that focal therapy for prostate cancer offers comparable long-term effectiveness to traditional radiotherapy and surgery with significantly fewer side effects. The research tracked nearly 3,500 men for a decade, with only two deaths from prostate cancer and a five-fold lower risk of side effects such as incontinence and erectile dysfunction compared to conventional treatments. The UK Government has announced additional funding to expand focal therapy provision, as currently only about 1,000 men per year receive the treatment despite up to 15,000 potentially eligible cases annually.ThelancetAlison Holmes: sustaining global attention on AMR - The LancetAlison Holmes, Director of the Fleming Initiative—a global partnership led by Imperial College London and Imperial College Healthcare NHS Trust to combat antimicrobial resistance (AMR)—is planning activities ahead of the 2028 centenary of Sir Alexander Fleming's discovery of penicillin. Holmes emphasizes the need to sustain political and policy focus on AMR as a major global challenge that disproportionately affects vulnerable populations, noting that research funding remains largely unrepresentative of those most impacted. The article discusses Holmes's dual role as Professor of Infectious Diseases at Imperial College London and the David Price Evans Chair in Infectious Diseases and Global Health at the University of Liverpool.Mirage NewsPioneering Study: Safe Twin Pregnancy Procedure FoundA first-in-human study led by Imperial College London and Imperial College Healthcare NHS Trust found that high intensity focused ultrasound (HIFU), a non-invasive procedure using high energy soundwaves, is safe and can successfully block blood flow in placental vessels causing twin-twin transfusion syndrome (TTTS). The trial involving 10 women from the UK and Europe achieved 90% success in blocking target blood vessels with no adverse side effects, though half required additional treatment and some babies did not survive. Researchers have received a £2.2 million grant to conduct a larger clinical trial of 50-100 women to determine if HIFU can effectively treat TTTS as a less invasive alternative to the current laser procedure.Mirage NewsNon-Invasive Twin Pregnancy Treatment Shows PromiseResearch led by Imperial College London and Imperial College Healthcare NHS Trust, involving several UK and European universities, has found that a non-invasive procedure using high-intensity focused ultrasound (HIFU) to treat twin-twin transfusion syndrome (TTTS) is safe and successfully blocked blood flow in 90% of treated placental vessels in a trial of ten pregnant women. The study reported no adverse side effects for mothers or twins, with 18 out of 20 pregnancies remaining healthy two weeks after treatment. Researchers now plan to conduct a larger clinical trial of 50 to 100 women to further validate the technique as a safer alternative to the current invasive laser surgery treatment.India.comObstructive sleep apnea increases cardiovascular risks by 71 per cent: StudyA new study has found that adults with obstructive sleep apnea have a 71 per cent higher risk of cardiovascular events or all-cause mortality compared to those without the condition, based on an analysis of electronic health records from 2.9 million residents. The research, conducted as a collaboration between Imperial College Health Partners, Imperial College Healthcare NHS Trust, and Eli Lilly and Company, matched 20,300 OSA patients with 97,412 controls, with over 57 per cent of OSA participants living with obesity. The findings, to be presented at the European Congress on Obesity 2026 in Istanbul, underscore the need for effective obesity management and early screening for OSA.Gadgets 360People With Obstructive Sleep Apnea Have 71% Higher Risk Of Heart Attacks, Stroke And Death: StudyScientists have found that people with obstructive sleep apnea have a 71% higher risk of cardiovascular events or all-cause mortality compared with those without the condition, based on a study using electronic health records from 2.9 million residents. The research, a collaboration between Imperial College Health Partners, Imperial College Healthcare NHS Trust, and Eli Lilly and Company, is the largest matched case-control study of obstructive sleep apnea outside the US to date. The findings underscore the need for effective obesity management and highlight the importance of early screening and timely diagnosis of OSA.ImperialImperial College Healthcare NHS TrustThe British Medical Association is planning a resident doctors' strike from 7am on 7 April to 7am on 13 April. Imperial College Healthcare NHS Trust will continue emergency services and most planned operations, with appointments rescheduled only if needed. Non-emergency help should go to GP, NHS 111, or 999 for emergencies.OracleOracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient CareOracle Health announced the general availability of its Clinical AI Agent, Clinical Note, in the UK following successful pilots at NHS Trusts including Barts Health NHS Trust, Imperial College Healthcare NHS Trust, and Milton Keynes University Hospital, which are now broadly deploying the solution. The AI uses ambient voice technology to auto-draft patient notes, cutting documentation time by approximately 40% and saving over 200,000 clinician hours in the US where it launched a year ago. Oracle has committed to investing $5 billion over the next five years in UK cloud infrastructure to support AI adoption across healthcare and other sectors.